Michael Reardon
In May 2024, The Diagnostic and Therapeutic Center of Athens Hygeia organized the Transcatheter Heart Valves Greece 2024. The conference featured pivotal specialty insights from both local faculty and internationally renowned professionals. Watch for more...
In May 2024, The Diagnostic and Therapeutic Center of Athens Hygeia organized the Transcatheter Heart Valves Greece 2024. The conference featured pivotal specialty insights from both local faculty and internationally...
In this recording from the 2023 Transcatheter Heart Valves Greece conference, Dr. Michael J. Reardon, a cardiothoracic surgeon at Methodist DeBaket Heart and Vascular Center, discusses varying confidence in the...
CTSNet had the great privilege of hosting an expert-filled roundtable on aortic root enlargement (AAE) vs. total root replacement (ARR) for the small aortic root. Barbara Hamilton moderated the debate...
CTSNet is excited to host a debate on the topic of aortic root enlargement (AAE) vs. total root replacement (ARR) for the small aortic root. Cardiac surgery experts Bo Yang,...
A complete surgical resection is the optimal treatment for heart tumors. In some cases (such as a large tumor or a tumor formed in a precarious location), the anatomic inaccessibility...
In an interview filmed at the 2015 STS Annual Meeting in San Diego, California, Tom Nguyen speaks with Michael Reardon, Chief of Cardiac Surgery at the Methodist DeBakey Heart &...
Purpose This is the case of a 64-year-old male who presented with right-sided heart failure symptoms. The patient had a severely dilated right sub-coronary sinus of Valsalva aneurysm, causing right...
Primary cardiac tumors are benign in 75% of cases, and malignant in the other 25%. Myxoma is the most common benign cardiac tumor. In 95% of these cases, the myxoma...








